Fennec Pharmaceuticals Inc. (NASDAQ: FENC)
$6.71
+0.1700 ( +2.60% ) 77.4K
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Market Data
Open
$6.71
Previous close
$6.54
Volume
77.4K
Market cap
$183.88M
Day range
$6.51 - $6.81
52 week range
$5.66 - $11.92
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 64 | May 14, 2024 |
| def | Proxies and info statements | 4 | May 13, 2024 |
| 8-k | 8K-related | 15 | May 09, 2024 |
| 4 | Insider transactions | 1 | May 02, 2024 |
| 4 | Insider transactions | 1 | May 02, 2024 |
| 4/a | Other | 1 | Apr 26, 2024 |
| 4/a | Other | 1 | Apr 26, 2024 |
| 4 | Insider transactions | 1 | Apr 22, 2024 |
| 4 | Insider transactions | 1 | Apr 18, 2024 |
| 4 | Insider transactions | 1 | Apr 16, 2024 |